168 related articles for article (PubMed ID: 6447671)
1. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
2. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
3. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
Perrymann F; Flournoy DJ; Qadri SM
Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
7. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
11. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
13. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.
Mason EO; Kaplan SL; Anderson DC; Hinds DB; Feigin RD
Antimicrob Agents Chemother; 1980 Mar; 17(3):470-3. PubMed ID: 6448579
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Goto S
Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
